Savannah Wilson, PA
Physician Assistant · Hutchinson, KSNPI 1720563984
Payments from drug & device makers
Across 49 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$114
- Sanofi$96
- Novo Nordisk$91
- Sanofi-aventis U.S. LLC$89
- Bayer$72
- Regeneron Healthcare Solutions, Inc.$56
- plus $452 from 18 others
What the payments were for
- Food & beverage$82585%
- Education$14515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 7 | $114 |
| Sanofi | 5 | $96 |
| Novo Nordisk | 5 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $89 |
| Bayer | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $56 |
| Amgen | 3 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $41 |
| AstraZeneca | 2 | $41 |
| AbbVie | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Novartis | 2 | $32 |
| Smith+Nephew | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Cochlear Americas | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| GSK | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Merck | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$970 in reported general payments places this provider in the 65th percentile of 1,016 physician assistant providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 57 | $2,070 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,247 |
| Famotidine | 102 | $793 |
| Omeprazole | 75 | $771 |
| Ciprofloxacin Hcl | 52 | $608 |
| Cefdinir | 27 | $550 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $419 |
| Fluticasone Propionate | 28 | $394 |
| Mupirocin | 36 | $243 |
| Doxycycline Hyclate | 20 | $232 |
| Terbinafine Hcl | 13 | $66 |
| Prednisone | 28 | $36 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Hutchinson
- Melanie SennHutchinson$9K
- Matthew OsenbaughHutchinson$9K
- Sierra WallaceHutchinson$7K
- Sierra FergusonWichita$25K
- Dylan TimmermannTopeka$19K
- Heather HowellKansas City$16K
- Amy BrettmanShawnee$14K
- Ashton YoungersWichita$14K
- Anthony GunawanLakin$13K
- Therese SchrandtWichita$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.